3.5 Adverse reactions
In the neoadjuvant treatment group, leukopenia appeared in 3 patients (20%), anemia in 1 patients (6.7%), periorbital edema in 7 patients (46.7%), and skin in 4 patients (26.6%). One patient developed grade 3 skin, and one patient developed grade 4 leukopenia. Two patients experienced dose adjustment due to adverse reactions.
In the adjuvant treatment group, nausea and vomiting appeared in 4 patients (10.5%), leukopenia in 6 patients (15.8%), anemia in 3 patients (7.9%), limb edema in 6 patients (15.8%), periorbital edema in 12 patients (31.6%), and skin in 7 patients (18.4%). One patient developed grade 3 leukopenia, and no adverse reaction of grade 4-5 occurred in all patients. Two patients experienced dose adjustment due to adverse reactions.